Acarbose Offers No CVD Protection in ACE, but May Cut Diabetes Risk Acarbose Offers No CVD Protection in ACE, but May Cut Diabetes Risk
A study of acarbose was conducted in a Chinese population with impaired glucose tolerance and established cardiovascular disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Postprandial Glucose Drug No Help for Established Heart Disease (CME/CE)
(MedPage Today) -- Acarbose delayed diabetes onset but didn ' t prevent CV events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 13, 2017 Category: Cardiology Source Type: news
Precose (Acarbose) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 31, 2017 Category: Drugs & Pharmacology Source Type: news
Precose (acarbose)
Title: Precose (acarbose)Category: MedicationsCreated: 4/28/2001 12:00:00 AMLast Editorial Review: 8/5/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 5, 2016 Category: Drugs & Pharmacology Source Type: news
Potential of Acarbose to Reduce Cardiovascular DiseasePotential of Acarbose to Reduce Cardiovascular Disease
Can this agent treat diabetes and reduce cardiovascular risk to boot? Cardiovascular Diabetology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Acarbose Cuts HbA1c on Par With Metformin (CME/CE)
(MedPage Today) -- Patients with newly diagnosed type 2 diabetes had similar improvement in glycemic control whether treated with acarbose (Precose) or metformin, investigators in a randomized trial reported. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 24, 2013 Category: Cardiology Source Type: news
Effects of Acarbose on GLP-1 in Newly Diagnosed T2D PatientsEffects of Acarbose on GLP-1 in Newly Diagnosed T2D Patients
Why does the antidiabetes drug acarbose decrease cardiovascular risk? Cardiovascular Diabetology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 3, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
